biotech
Taking a look behind the scenes of Serialisation
February 12, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Serialization, biotech, drugs, pharma, pharmaceutical, serialisation
The reaction from the pharmaceutical industry has been mixed since the announcement of serialisation requirements. Ben Hargreaves discovers the challenges …
Sanofi in $155m influenza vaccine deal
February 12, 2018Sales and Marketing SK Chemicals, Sanofi, Sanofi Pasteur, biotech, drugs, pharma, pharmaceutical
Sanofi has revealed that it has agreed a deal with SK Chemicals, a South Korean vaccine manufacturer, to license its …
Trump’s drug pricing reforms lack bite
February 12, 2018Sales and Marketing Drug pricing, President trump, Trump, biotech, drugs, pharma, pharmaceutical
President Trump’s rhetoric leading up to his election had the pharmaceutical industry very worried – his often quoted line about …
MannKind entices Lilly VP to CMO role
February 9, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eli Lilly, Mannkind, biotech, drugs, pharma, pharmaceutical
MannKind, the California-based biotech, announced that David Kendall would be joining its team as Chief Medical Officer and would be …
SFO bribery investigation into GSK opens old wounds
February 9, 2018Medical Communications GSK, biotech, drugs, pharma, pharmaceutical
A small titbit of information was buried within GSK’s financials this week, which threatens to bring up old news that …
Fujifilm partners with Takeda, stepping into regenerative medicine
February 9, 2018Medical Communications, Research and Development Fujifilm, Takeda, biotech, drugs, pharma, pharmaceutical
Fujifilm has been steadily building up its regenerative medicines, with several acquisitions of companies that hold expertise in the area …
Migraine drug bad news hits a weakened Teva
February 9, 2018Medical Communications, Sales and Marketing CGRP, Teva, biotech, drugs, pharma, pharmaceutical
The cacophony of bad news that Teva has received in 2017 really needs no retelling, anyone following the story of …
Dr Reddy’s hit by yet another recall, of 80,000+ bottles
February 8, 2018Sales and Marketing Dr Reddy's, FDA, biotech, drugs, pharma, pharmaceutical
Dr Reddy’s Laboratories problem with ensuring products reach the market at a quality the FDA deems acceptable is no secret …
Novartis tastes own medicine, Advair generic delayed
February 8, 2018Sales and Marketing FDA, Novartis, biotech, drugs, pharma, pharmaceutical
Novartis had not been frontrunner to receive approval for its generic version of GSK’s Advair – lagging behind Mylan’s generic …
Theravance seals potential $1bn deal with J&J
February 8, 2018Sales and Marketing Johnson & Johnson, Theravance Biopharma, biotech, drugs, pharma, pharmaceutical
The JAK inhibitor field is beginning to heat up – AbbVie is soon to enter Phase 3 with its predicted …
CEO gets the axe: Arcturus relieve Payne of position
February 7, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Arcturus, biotech, drugs, pharma, pharmaceutical
Early in February, Arcturus Therapeutics revealed that it had let its CEO, Joseph Payne, go and had replaced him as …
Array’s melanoma therapy blasts Roche’s out of water
February 7, 2018Research and Development Array Biopharma, Pierre Fabre, Roche, biotech, drugs, melanoma, pharma, pharmaceutical
Array Biopharma suffered a serious knock back in early 2017 when its plan to commercialise its drug, binimetinib, were derailed …
NHS tells doctors to order stronger vaccine for next winter
February 7, 2018Medical Communications, Research and Development NHS, biotech, drugs, flu season, pharma, pharmaceutical
England is not alone in being particularly hard hit this flu season, with Australia suffering its worst flu season in …
New breakthrough for CGRP migraine treatments
February 6, 2018Research and Development Allergan, Amgen, CGRP, Novartis, biotech, drugs, pharma, pharmaceutical
Allergan had a rough year in 2017, dropping by close to $80 a share from February 2017 to this month. …
Allergan successfully concludes CFO search
February 6, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, biotech, drugs, pharma, pharmaceutical
Allergan has been searching for a new Chief Financial Officer since Tessa Hilado, its current CFO, revealed that she would …
Latest content
